Literature DB >> 9773983

Estrogen receptor activation function 1 works by binding p160 coactivator proteins.

P Webb1, P Nguyen, J Shinsako, C Anderson, W Feng, M P Nguyen, D Chen, S M Huang, S Subramanian, E McKinerney, B S Katzenellenbogen, M R Stallcup, P J Kushner.   

Abstract

Estrogen receptor-alpha contains two transactivation functions, a weak constitutive activation function (AF-1) and a hormone-dependent activation function (AF-2). AF-2 works by recruiting a large coactivator complex, composed of one or more p160s, CREB-binding protein (CBP)/p300, and P/CAF (p300 and CBP-associated factor), via direct contacts with the p160s. We report here that independent AF-1 activity also requires p160 contacts. Unlike AF-2, which binds signature NR boxes in the center of the p160 molecule, AF-1 binds to sequences near the p160 C terminus. We propose that the ability of AF-1 and AF-2 to interact with separate surfaces of the same coactivator is important for the ability of these transactivation functions to synergize.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773983     DOI: 10.1210/mend.12.10.0185

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  93 in total

1.  Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1.

Authors:  F M Sladek; M D Ruse; L Nepomuceno; S M Huang; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

2.  Molecular determinants of the estrogen receptor-coactivator interface.

Authors:  H Y Mak; S Hoare; P M Henttu; M G Parker
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 3.  Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling.

Authors:  Paul H Driggers; James H Segars
Journal:  Trends Endocrinol Metab       Date:  2002-12       Impact factor: 12.015

4.  Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.

Authors:  Xiaodong Li; Jing Huang; Ping Yi; Robert A Bambara; Russell Hilf; Mesut Muyan
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding.

Authors:  Raj Kumar; Carmen M Moure; Shagufta H Khan; Celetta Callaway; Sandra L Grimm; Devrishi Goswami; Patrick R Griffin; Dean P Edwards
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

Review 6.  Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations.

Authors:  Derek N Lavery; Iain J McEwan
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

7.  Transcriptional intermediary factor 1alpha mediates physical interaction and functional synergy between the coactivator-associated arginine methyltransferase 1 and glucocorticoid receptor-interacting protein 1 nuclear receptor coactivators.

Authors:  Catherine Teyssier; Chen-Yin Ou; Konstantin Khetchoumian; Régine Losson; Michael R Stallcup
Journal:  Mol Endocrinol       Date:  2005-12-01

8.  Structural plasticity in the oestrogen receptor ligand-binding domain.

Authors:  Kendall W Nettles; John B Bruning; German Gil; Erin E O'Neill; Jason Nowak; Yuee Guo; Alun Hughs; Younchang Kim; Eugene R DeSombre; Robert Dilis; Robert N Hanson; Andrzej Joachimiak; Geoffrey L Greene
Journal:  EMBO Rep       Date:  2007-04-27       Impact factor: 8.807

9.  Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.

Authors:  Lonnele J Ball; Nitzan Levy; Xiaoyue Zhao; Chandi Griffin; Mary Tagliaferri; Isaac Cohen; William A Ricke; Terence P Speed; Gary L Firestone; Dale C Leitman
Journal:  Mol Cell Endocrinol       Date:  2008-11-18       Impact factor: 4.102

10.  Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1.

Authors:  Marion Desclozeaux; Irina N Krylova; Florence Horn; Robert J Fletterick; Holly A Ingraham
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.